A cellular and immune therapy company named Gamida Cell is launching a Phase I study for relapsed or refractory Multiple Myeloma Patients that uses NAM-expanded Natural Killer Cells (NAM-NK Cells). Natural killer cells are lymphoid cells that play an important role in the immune system and are effective in killing infected or cancerous cells. While T [...]
This post first appeared on Page Not Found - The Myeloma Crowd, please read the originial post: here
